Physician profile
David Haiwei Ge
NPI 1386105575
$40,042.56
in general payments reported to CMS, 2019-2025
10 companies · $32K in 2025
The $32K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $7,730 · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $32K · Travel and Lodging: $5,213 · Food and Beverage: $2,368 · Education: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $31,500.00 |
| Travel and Lodging | $5,213.02 |
| Food and Beverage | $2,368.26 |
| Education | $961.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,165.04 | 2024-2025 | |
| Smith+Nephew, INC. | $13,857.83 | 2024-2025 | Double Endobutton, Coblation, Cap-Fix |
| Stryker Corporation | $1,549.02 | 2024-2025 | Inspace, Alphavent, Na |
| Medtronic, INC. | $1,500.00 | 2025 | Infuse Bone Graft |
| Medical Device Business Services, INC. | $1,163.56 | 2024 | |
| Depuy Synthes Sales INC. | $650.61 | 2024-2025 | Truespan Orthocord, Dynacord, Na |
| Tricoast Surgical Solutions LLC | $72.35 | 2025 | |
| Orthopediatrics Corp. | $33.92 | 2024 | |
| Polynovo North America LLC | $29.94 | 2024 | Novosorb Btm |
| Vericel Corporation | $20.29 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.